Minimizing the risk of reporting false positives in large-scale RNAi screens

Echeverri, Christophe J; Beachy, Philip A; Baum, Buzz; Boutros, Michael; Buchholz, Frank; Chanda, Sumit K; Downward, Julian; Ellenberg, Jan; Fraser, Andrew G; Hacohen, Nir; Hahn, William C; Jackson, Aimee L; Kiger, Amy; Linsley, Peter S; Lum, Lawrence; Ma, Yong; Mathey-Prevot, Bernard; Root, David E; Sabatini, David M; Taipale, Jussi; Perrimon, Norbert; Bernards, Rene

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Minimizing the risk of reporting false positives in large-scale RNAi screens

MPS-Authors

/persons/resource/persons219042

Buchholz, Frank
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Echeverri, C. J., Beachy, P. A., Baum, B., Boutros, M., Buchholz, F., Chanda, S. K., et al. (2006). Minimizing the risk of reporting false positives in large-scale RNAi screens. Nature Methods, 3(10), 777-779.

Cite as: https://hdl.handle.net/21.11116/0000-0001-106A-6

Abstract

Large-scale RNA interference (RNAi)-based analyses, very much as other 'omic' approaches, have inherent rates of false positives and negatives. The variability in the standards of care applied to validate results from these studies, if left unchecked, could eventually begin to undermine the credibility of RNAi as a powerful functional approach. This Commentary is an invitation to an open discussion started among various users of RNAi to set forth accepted standards that would insure the quality and accuracy of information in the large datasets coming out of genome-scale screens.